Kyongbo Pharmaceutical Co., Ltd (KRX:214390)

Kyongbo Pharmaceutical Revenue

Kyongbo Pharmaceutical had revenue of 60.59B KRW in the quarter ending March 31, 2025, a decrease of -3.21%. This brings the company's revenue in the last twelve months to 236.54B, up 2.40% year-over-year. In the year 2024, Kyongbo Pharmaceutical had annual revenue of 238.56B with 10.26% growth.

• Revenue (ttm): 236.54B
• Revenue Growth: +2.40%
• P/S Ratio: 0.50
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 119.30B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	238.56B	22.20B	10.26%
Dec 31, 2023	216.36B	20.09B	10.24%
Dec 31, 2022	196.26B	25.61B	15.00%
Dec 31, 2021	170.66B	-44.63B	-20.73%
Dec 31, 2020	215.29B	23.58B	12.30%